How cell and gene therapy developers can lessen the chances of receiving FDA complete response letters through the use of proactive chemistry, manufacturing, and controls strategies.

Vivek Subbiah, MD, considers artificial intelligence (AI) and comprehensive somatic and germline testing essential for guiding precision oncology and improving patient care.

iconPCR is transforming PCR assay development. DOE research that at one point required dozens of plates and long hours at the ...

Doctors can order genetic tests for people at high risk of breast cancer, and insurance often covers those, Kamal says. For ...

In honor of Breast Cancer Awareness Month, the TODAY show, with the help of breast cancer survivors Jill Martin and Sheryl ...